*Correspondence: Ateya M
I am down 19 more pounds in 10 weeks and my waist is shrinking faster
this cost analysis reflects independent judgment alone
However, due to (i) rareness of the disease (unfamiliar to most neurologists), (ii) non-inclusion of GNE genetic testing for neurological indications, and (iii) non-specific symptoms at disease onset (foot-drop, balance impairment), the diagnosis of these patients is difficult and often delayed
With the efficacy ceiling now set at 28%, durable value creation will depend less on incremental weight loss and more on the ability to address persistent clinical unmet needs (tolerability, convenience, personalization, maintenance, refractory obesity and weight-loss quality) in ways that translate into real-world adherence, payer relevance and chronic care scalability
Rather than waiting for trends to be defined solely by clinical research or large-scale institutional studies, audiences are actively shaping the conversation through digital communities, personal experimentation, and selective adoption of new products
